Japan's First CRO CMIC On How ICH Affects Clinical Trials in Japan: An Interview CMIC's With Moriaki Akasaki (Pt. 2)
This article was originally published in The Pink Sheet Daily
Executive Summary
CMIC executive discusses quality control and informed consent, and the meaning of "extravagent" trials under Japanese regulations.